Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The antigenic identity of human class I MHC phosphopeptides is critically dependent upon phosphorylation status
Fiyaz Mohammed, Daniel H. Stones, Angela L. Zarling, et al.
Oncotarget (2017) Vol. 8, Iss. 33, pp. 54160-54172
Open Access | Times Cited: 49

Showing 1-25 of 49 citing articles:

Post-translational modifications reshape the antigenic landscape of the MHC I immunopeptidome in tumors
Assaf Kacen, Aaron Javitt, Matthias P. Kramer, et al.
Nature Biotechnology (2022) Vol. 41, Iss. 2, pp. 239-251
Closed Access | Times Cited: 65
Structure-based Methods for Binding Mode and Binding Affinity Prediction for Peptide-MHC Complexes
Dinler A. Antunes, Jayvee R. Abella, Didier Devaurs, et al.
Current Topics in Medicinal Chemistry (2019) Vol. 18, Iss. 26, pp. 2239-2255
Open Access | Times Cited: 69
MHC-restricted phosphopeptide antigens: preclinical validation and first-in-humans clinical trial in participants with high-risk melanoma
Víctor H. Engelhard, Rebecca C. Obeng, Kara L. Cummings, et al.
Journal for ImmunoTherapy of Cancer (2020) Vol. 8, Iss. 1, pp. e000262-e000262
Open Access | Times Cited: 65
Mass Spectrometry Based Immunopeptidomics Leads to Robust Predictions of Phosphorylated HLA Class I Ligands
Marthe Solleder, Philippe Guillaume, Julien Racle, et al.
Molecular & Cellular Proteomics (2019) Vol. 19, Iss. 2, pp. 390-404
Open Access | Times Cited: 58
Structures of the four Ig-like domain LILRB2 and the four-domain LILRB1 and HLA-G1 complex
Qihui Wang, Hao Song, Hao Cheng, et al.
Cellular and Molecular Immunology (2019) Vol. 17, Iss. 9, pp. 966-975
Open Access | Times Cited: 45
Mass Spectrometry-Based Identification of MHC-Associated Peptides
Sachin Kote, Artur Piróg, Georges Bedran, et al.
Cancers (2020) Vol. 12, Iss. 3, pp. 535-535
Open Access | Times Cited: 41
Main Strategies for the Identification of Neoantigens
Alexander V. Gopanenko, Е. Н. Кособокова, В. С. Косоруков
Cancers (2020) Vol. 12, Iss. 10, pp. 2879-2879
Open Access | Times Cited: 37
A Roadmap Toward the Definition of Actionable Tumor-Specific Antigens
Robin Minati, Claude Perreault, Pierre Thibault
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 33
The Hunt lab weighs in on mass spectrometry-based analysis of protein post-translational modifications
Joshua J. Coon, Jarrod A. Marto, John E. P. Syka, et al.
Molecular & Cellular Proteomics (2025), pp. 100943-100943
Open Access
Identification of post-translationally modified MHC class I-associated peptides as potential cancer immunotherapeutic targets
Keira E. Mahoney, Larry Reser, Maria Virginia Ruiz Cuevas, et al.
Molecular & Cellular Proteomics (2025), pp. 100971-100971
Open Access
Empirical and Rational Design of T Cell Receptor-Based Immunotherapies
Heather F. Jones, Zaki Molvi, Martin G. Klatt, et al.
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 26
Molecular mechanism of phosphopeptide neoantigen immunogenicity
Y. Patskovsky, Aswin Natarajan, Larysa Patskovska, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 10
Rosetta FlexPepDock to predict peptide-MHC binding: An approach for non-canonical amino acids
Nathaniel Bloodworth, Natália R. Barbaro, Rocco Moretti, et al.
PLoS ONE (2022) Vol. 17, Iss. 12, pp. e0275759-e0275759
Open Access | Times Cited: 15
A TCR mimic monoclonal antibody reactive with the “public” phospho-neoantigen pIRS2/HLA-A*02:01 complex
Tao Dao, Sung Soo Mun, Zaki Molvi, et al.
JCI Insight (2022) Vol. 7, Iss. 5
Open Access | Times Cited: 13
Mining the Immunopeptidome for Antigenic Peptides in Cancer
Ricardo A. León-Letelier, Hiroyuki Katayama, Samir Hanash
Cancers (2022) Vol. 14, Iss. 20, pp. 4968-4968
Open Access | Times Cited: 13
A Chemical Approach to Assess the Impact of Post-translational Modification on MHC Peptide Binding and Effector Cell Engagement
Joey J. Kelly, Nathaniel Bloodworth, Qianqian Shao, et al.
ACS Chemical Biology (2024) Vol. 19, Iss. 9, pp. 1991-2001
Open Access | Times Cited: 2
Vaccine Strategy in Melanoma
Minyoung Kwak, Katie M. Leick, Marit M. Melssen, et al.
Surgical Oncology Clinics of North America (2019) Vol. 28, Iss. 3, pp. 337-351
Open Access | Times Cited: 22
The intersection of affinity and specificity in the development and optimization of T cell receptor based therapeutics
Timothy P. Riley, Brian M. Baker
Seminars in Cell and Developmental Biology (2018) Vol. 84, pp. 30-41
Open Access | Times Cited: 21
Predicting Immunogenicity Risk in Biopharmaceuticals
Nikolet Doneva, Irini Doytchinova, Ivan Dimitrov
Symmetry (2021) Vol. 13, Iss. 3, pp. 388-388
Open Access | Times Cited: 17
Tumor Infiltrating Lymphocytes Target HLA-I Phosphopeptides Derived From Cancer Signaling in Colorectal Cancer
Sarah Penny, Jennifer G. Abelin, Stacy A. Malaker, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 17
Structural aspects of chemical modifications in the MHC-restricted immunopeptidome; Implications for immune recognition
Tatyana Sandalova, Benedetta Maria Sala, Adnane Achour
Frontiers in Chemistry (2022) Vol. 10
Open Access | Times Cited: 11
Immunoproteomics Methods and Techniques
Kelly M. Fulton, Isabel Baltat, Susan M. Twine
Methods in molecular biology (2019), pp. 25-58
Closed Access | Times Cited: 18
MHC Phosphopeptides: Promising Targets for Immunotherapy of Cancer and Other Chronic Diseases
Keira E. Mahoney, Jeffrey Shabanowitz, Donald F. Hunt
Molecular & Cellular Proteomics (2021) Vol. 20, pp. 100112-100112
Open Access | Times Cited: 15
Structural basis for the recognition of nectin-like protein-5 by the human-activating immune receptor, DNAM-1
Felix A. Deuss, G. M. Watson, Katharine J. Goodall, et al.
Journal of Biological Chemistry (2019) Vol. 294, Iss. 33, pp. 12534-12546
Open Access | Times Cited: 14
Murine xenograft bioreactors for human immunopeptidome discovery
James Heather, Paisley T. Myers, Feng Shi, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top